Related Experiment Videos
[Liver resection in patients with polycystic liver disease]
C Vons1, D Chauveau, E Martinod
1Service (1) de Chirurgie, Hôpital Antoine-Béclère, Clamart.
Gastroenterologie Clinique Et Biologique
|October 8, 1998
Summary
Partial liver resection effectively treats symptomatic polycystic liver disease, reducing hepatomegaly and complications. Early intervention before end-stage renal failure offers the best outcomes for patients with this condition.
Area of Science:
- Hepatobiliary surgery
- Gastroenterology
- Nephrology
Context:
- Polycystic liver disease (PLD) causes chronic symptoms and complications like hepatomegaly, hemorrhage, and cyst infections.
- Management of PLD, especially in patients with co-existing end-stage renal failure, presents significant challenges.
Purpose:
- To evaluate the efficacy of partial liver resection for symptomatic or complicated polycystic liver disease.
- To assess outcomes in patients undergoing various partial hepatectomy procedures for PLD.
Summary:
- A retrospective study of 12 PLD patients (mean age 49) treated with partial liver resection (lobectomy or hepatectomy).
- Postoperative ascites occurred in 83% of patients, particularly those with end-stage renal failure.
- Ten patients experienced significant improvement, including reduced hepatomegaly and symptom resolution; two surviving patients with end-stage renal failure required kidney transplantation for complete recovery.
Impact:
- Partial liver resection is a highly effective treatment for symptomatic PLD.
- Early surgical intervention in PLD patients, prior to end-stage renal failure, is recommended for optimal results.
- This approach can significantly improve quality of life and reduce disease-related morbidity.